Published August 2017 | Version v1
Journal article

Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution

  • 1. Institute of Clinical Medicine, University of Oslo, Oslo (Norway)
  • 2. Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo (Norway)
  • 3. Oncoinvent AS, Oslo (Norway)
  • 4. Nordic Nanovector ASA, Oslo (Norway)
  • 5. Sciencons AS, Oslo (Norway)

Description

Alpha-emitting radionuclides have gained considerable attention as payloads for cancer targeting molecules due to their high cytotoxicity. One attractive radionuclide for this purpose is 212Pb, which by itself is a β-emitter, but acts as an in vivo generator for its short-lived α-emitting daughters. The standard method of preparing 212Pb-labeled antibodies requires handling and evaporation of strong acids containing high radioactivity levels by the end user. An operationally easier and more rapid process could be useful since the 10.6 h half-life of 212Pb puts time constraints on the preparation protocol. In this study, an in situ procedure for antibody labeling with 212Pb, using a solution of the generator nuclide 224Ra, is proposed as an alternative protocol for preparing 212Pb-radioimmunoconjugates.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.nucmedbio.2017.04.005

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2017.04.005;
PII
S0969805117300586;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
51
Journal Page Range
p. 1-9
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2017 The Authors. Published by Elsevier Inc.